000 01571 a2200421 4500
005 20250517022930.0
264 0 _c20150707
008 201507s 0 0 eng d
022 _a1521-7035
024 7 _a10.1016/j.clim.2015.03.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchneiders, Famke L
245 0 0 _aAminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.
_h[electronic resource]
260 _bClinical immunology (Orlando, Fla.)
_cMay 2015
300 _a92-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmines
_xpharmacology
650 0 4 _aAntigen Presentation
_xdrug effects
650 0 4 _aAntigens, CD1d
_ximmunology
650 0 4 _aBone Density Conservation Agents
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aDendritic Cells
_xdrug effects
650 0 4 _aDiphosphonates
_xpharmacology
650 0 4 _aGalactosylceramides
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aNatural Killer T-Cells
_xdrug effects
700 1 _aHuijts, Charlotte M
700 1 _aMantici, Aslihan
700 1 _aMenks, Mica A C
700 1 _aScotet, Emmanuel
700 1 _aVeerhuis, Rob
700 1 _aVerheul, Henk M W
700 1 _ade Gruijl, Tanja D
700 1 _avan der Vliet, Hans J
773 0 _tClinical immunology (Orlando, Fla.)
_gvol. 158
_gno. 1
_gp. 92-9
856 4 0 _uhttps://doi.org/10.1016/j.clim.2015.03.007
_zAvailable from publisher's website
999 _c24729771
_d24729771